Mayfield on Scaling Biotech Startups

Navigating the Initial Hurdles of Startup Development

Founders at the very beginning of their startup journey often encounter a significant learning process. Essential skills to master include securing VC funding, attracting talented individuals, achieving product-market fit, and assembling an effective go-to-market team. The demands are numerous and continuous.

These topics, and many others, will be comprehensively covered at TechCrunch Early Stage Operations & Fundraising, scheduled for April 1-2.

A Session for Science-Driven Entrepreneurs

Are you grounded in scientific principles? Do you envision applying biological advancements to technological innovation? If your entrepreneurial focus lies within the scientific realm, a specialized session at TC Early Stage 2021, occurring on April 1-2 and presented by Mayfield, is a must-attend.

Scaling Engineering Biology Companies: Insights for Scientist Entrepreneurs

Arvind Gupta and Ursheet Parikh, partners at Mayfield with extensive experience in company building and early-stage investment, will lead a discussion. They will be joined by Po Bronson, managing director of IndieBio and a New York Times bestselling author.

The conversation will center on the challenges of scaling startups, with a particular focus on three critical areas that shape a company’s growth: fundraising, hiring, and product design.

Their perspectives are informed by their work with companies such as Geltor, a leader in ingredients-as-service, which secured a $91 million Series B round in 2020. Also featured are Mammoth Biosciences, a CRISPR platform boasting co-founder and Nobel Laureate Jennifer Doudna, and Endpoint Health, founded by the team behind GeneWEAVE and former YC Bio Partner Diego Rey.

Building a Successful Science-Based Startup

This session is designed to benefit biotech entrepreneurs, researchers, and scientists dedicated to addressing complex issues in human and planetary health. It will provide valuable guidance for constructing a more robust and successful startup as you prepare to launch your product.

Mayfield plans to expand on these discussions with further content at Disrupt 2021 in September. These future sessions will offer company-building strategies from entrepreneurs, investors, industry experts, and policymakers.

Mayfield is dedicated to investing in exceptional individuals committed to creating a positive impact on the world, for both current and future generations. If you have a scientific background, seize the opportunity to learn from leading investors who have collaborated with prominent biotech and health IT entrepreneurs, including those from Amgen, Genentech, and Mammoth Biosciences.

Secure your ticket for the April TC Early Stage event here. Alternatively, consider a dual-event ticket for both the April and July events to gain comprehensive knowledge across operations, marketing, recruiting, and fundraising – and potentially save up to $100.

For companies interested in sponsorship or exhibition opportunities at Early Stage 2021 – Operations & Fundraising, please contact our sponsorship sales team by completing this form.